Evidence map›Paper›PMID 34808214›Full record

ArticleJournal of pharmaceutical sciences2022

An Interlaboratory Comparison on the Characterization of a Sub-micrometer Polydisperse Particle Dispersion.

Kurt D Benkstein, Gurusamy Balakrishnan, Ashwinkumar Bhirde, Pascal Chalus, Tapan K Das, Ngoc Do, David L Duewer, Nazar Filonov, Fook Chiong Cheong, Patrick Garidel and 26 more

Abstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Kurt D BenksteinBiomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA. Electronic address: kurt.benkstein@nist.gov.
Gurusamy BalakrishnanAnalytical Development and Attribute Science, Bristol Myers Squibb, New Brunswick, NJ 08901, USA.
Ashwinkumar BhirdeOffice of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
Pascal ChalusLonza AG, Drug Product Services, Hochbergerstrasse 60G, CH-4057 Basel, Switzerland.
Tapan K DasBiologics Development, Bristol Myers Squibb, New Brunswick, NJ 08903, USA.
Ngoc DoSpectradyne LLC, 23875 Madison St Suite A, Torrance CA 90505, USA.
David L DuewerChemical Sciences Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA.
Nazar FilonovAlphaNanoTech, Morrisville, NC 27709, USA; Particle Metrix, Inc., Mebane, NC 27302, USA.
Fook Chiong CheongSpheryx, Inc., New York, NY 10016, USA.
Patrick GaridelBoehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, PDB, D-88397 Biberach an der Riss, Germany.
Nicole S GillYokogawa Fluid Imaging Technologies, Inc. Scarborough, ME 04074, USA.
Adam D GrabarekCoriolis Pharma, Fraunhoferstrasse 18 b, 82152 Martinsried, Germany; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.
David G GrierDepartment of Physics and Center for Soft Matter Research, New York University, New York, NY 10003, USA.
Judith HadleyMalvern Pananalytical, 117 Flanders Road Westborough, MA 01581, USA.
Andrew D HollingsworthDepartment of Physics and Center for Soft Matter Research, New York University, New York, NY 10003, USA.
Wesley W HowardAnalytical Sciences, BioPharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, USA.
Maciej JarzębskiDepartment of Physics and Biophysics, Faculty of Food Science and Nutrition, Poznan University of Life Sciences, Poznan, Poland.
Wim JiskootDivision of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.
Sambit R KarBiologics Development, Bristol Myers Squibb, New Brunswick, NJ 08903, USA.
Vikram KestensEuropean Commission, Joint Research Centre (JRC), Geel, Belgium.
Harshit KhasaAnalytical Sciences, BioPharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, USA.
Yoen Joo KimAnalytical Sciences, BioPharmaceuticals Development, R&D, AstraZeneca, Gaithersburg, USA.
Atanas KoulovLonza AG, Drug Product Services, Hochbergerstrasse 60G, CH-4057 Basel, Switzerland.
Anja MatterLonza AG, Drug Product Services, Hochbergerstrasse 60G, CH-4057 Basel, Switzerland.
Laura A PhilipsSpheryx, Inc., New York, NY 10016, USA.
Christine ProbstLuminex Corporation, Seattle, WA 98119, USA.
Yannic RamayeEuropean Commission, Joint Research Centre (JRC), Geel, Belgium.
Theodore W RandolphDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309.
Dean C RippleBiomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA.
Stefan RomeijnDivision of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands.
Miguel SagguPharmaceutical Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Franziska SchleinzerBoehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, PDB, D-88397 Biberach an der Riss, Germany.
Jared R SnellDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309.
Jan Kuba TatarkiewiczHORIBA Scientific, Irvine, CA 92618, USA.
Heather Anne WrightYokogawa Fluid Imaging Technologies, Inc. Scarborough, ME 04074, USA.
Dennis T YangBiopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.

Funding

Instrument for Holographic Characterization of Protein Aggregates - This SBIR Phase II program is developing an instrument that uses holographic video microscopy to meet quality needs for biologics.R44TR001590 · NCATS · SPHERYX, INC. · PI PHILIPS, LAURA A · 2017 to 2021
$3.6M
Intramural NIST DOC 9999-NISTNCATS NIH HHS R44 TR001590
6 · The paper itself

Abstract

The measurement of polydisperse protein aggregates and particles in biotherapeutics remains a challenge, especially for particles with diameters of ≈ 1 µm and below (sub-micrometer). This paper describes an interlaboratory comparison with the goal of assessing the measurement variability for the characterization of a sub-micrometer polydisperse particle dispersion composed of five sub-populations of poly(methyl methacrylate) (PMMA) and silica beads. The study included 20 participating laboratories from industry, academia, and government, and a variety of state-of-the-art particle-counting instruments. The received datasets were organized by instrument class to enable comparison of intralaboratory and interlaboratory performance. The main findings included high variability between datasets from different laboratories, with coefficients of variation from 13 % to 189 %. Intralaboratory variability was, on average, 37 % of the interlaboratory variability for an instrument class and particle sub-population. Drop-offs at either end of the size range and poor agreement on maximum counts of particle sub-populations were noted. The mean distributions from an instrument class, however, showed the size-coverage range for that class. The study shows that a polydisperse sample can be used to assess performance capabilities of an instrument set-up (including hardware, software, and user settings) and provides guidance for the development of polydisperse reference materials.

Indexed as

LaboratoriesSoftwareParticle Size

Identifiers

PMID34808214
PMCPMC9912188

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.